1. Clinical values of gene alterations as marker of minimal residual disease in non-M3 acute myeloid leukemia
   Tingyu Yu et al, 2021, Hematology CrossRef
2. Targeted Therapy in Pediatric AML: An Evolving Landscape
   LaQuita M. Jones et al, 2021, Pediatric Drugs CrossRef
3. Genomic alterations in a cohort of pediatric acute myeloid leukemia patients at two cancer centers in Colombia
   Luz K. Yunis et al, 2023, International Journal of Hematology CrossRef
4. Epigenomic machinery regulating pediatric AML: Clonal expansion mechanisms, therapies, and future perspectives
   Ugo Chianese et al, 2023, Seminars in Cancer Biology CrossRef